Tenet Healthcare (THC) Stock Price, News & Analysis

Company Overview

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities. These centers provide same-day surgical procedures and related diagnostic and treatment services, supporting the company’s focus on expanding outpatient care.

Tenet traces its roots to 1967 and was formerly known as National Medical Enterprises before adopting the Tenet Healthcare name in 1995. The company primarily serves communities across the United States. Saum Sutaria has served as Tenet’s president and chief executive officer since 2022.

Key Stats

• Today's Range: $262.01 to $270.25
• 50-Day Range: $183.60 to $280.60
• 52-Week Range: $157.58 to $283.05
• Volume: 618,667 shs
• Average Volume: 712,145 shs
• Market Capitalization: $21.33 billion
• P/E Ratio: 10.21
• Dividend Yield: N/A
• Price Target: $275.53
• Consensus Rating: Buy

Tenet Healthcare Stock Analysis - MarketRank™

Tenet Healthcare scored higher than 76% of companies evaluated by MarketBeat, and ranked 163rd out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Buy

Consensus Rating

Tenet Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 18 buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for Tenet Healthcare is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Tenet Healthcare has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: -1.00%

Earnings Growth

Earnings for Tenet Healthcare are expected to decrease by -1.00% in the coming year, from $21.04 to $20.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tenet Healthcare is 10.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tenet Healthcare is 10.21, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.99.

Price to Earnings Growth Ratio

Tenet Healthcare has a PEG Ratio of 1.01. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

Tenet Healthcare has a P/B Ratio of 3.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.37% of the float of Tenet Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Tenet Healthcare has a short interest ratio ("days to cover") of 2.53, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenet Healthcare has recently decreased by 25.17%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tenet Healthcare does not currently pay a dividend.

Dividend Growth

Tenet Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.77

News Sentiment

Tenet Healthcare has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for Tenet Healthcare this week, compared to 5 articles on an average week.

Search Interest

18 people have searched for THC on MarketBeat in the last 30 days. This is an increase of 64% compared to the previous 30 days.

MarketBeat Follows

1 people have added Tenet Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tenet Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $31,898,309.00 in company stock.

Percentage Held by Insiders

0.97% of the stock of Tenet Healthcare is held by insiders.

Percentage Held by Institutions

95.44% of the stock of Tenet Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/23/2026
• Today: 9/14/2026
• Next Earnings (Estimated): 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:THC
• CIK: 70318
• Web: www.tenethealth.com
• Phone: (469) 893-2200
• Fax: 469-893-8600
• Employees: 99,000
• Year Founded: 1969

Price Target and Rating

• Average Price Target for Tenet Healthcare: $275.53
• High Price Target: $308.00
• Low Price Target: $225.00
• Potential Upside/Downside: +4.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 20 Analysts

Profitability

• EPS (Trailing Twelve Months): $25.93
• Trailing P/E Ratio: 10.21
• Forward P/E Ratio: 12.59
• P/E Growth: 1.01
• Net Income: $1.41 billion
• Net Margins: 10.27%
• Pretax Margin: 17.72%
• Return on Equity: 26.76%
• Return on Assets: 5.55%

Debt

• Debt-to-Equity Ratio: 2.00
• Current Ratio: 1.41
• Quick Ratio: 1.35

Sales & Book Value

• Annual Sales: $21.31 billion
• Price / Sales: 1.00
• Cash Flow: $27.82 per share
• Price / Cash Flow: 9.52
• Book Value: $69.19 per share
• Price / Book: 3.83

Miscellaneous

• Outstanding Shares: 80,520,000
• Free Float: 79,738,000
• Market Cap: $21.33 billion
• Optionable: Optionable
• Beta: 1.23